Connect your AI

Bio-Techne TECH Exosome Diagnostics Inc — Receivables Fair Value Disclosure

Similar metrics at other companies

BXLoans Receivable Fair Value Disclosure

$425.98M+270%

PCARFinancial Services — Loans Receivable Fair Value Disclosure

$9.94B+7.8%

BACLoans Receivable Fair Value Disclosure

$3.76B-30.2%

APODebt Instrument, Fair Value Disclosure

$13.47B+32.4%

MSCIDebt Instrument, Fair Value Disclosure

$6.13B+44.7%

SOFair Value Measurement Disclosure

$401M—

Other financials

Income statement

Revenue$311.4M-1.5%

Gross profit$208.3M-2.9%

Operating income$75.5M+95.0%

Net income$51.0M+126%

EPS (diluted)$0.32+129%

Balance sheet

Cash & equivalents$209.8M+49.2%

Total debt$290.3M-31.4%

Total equity$2.1B+3.3%

Total assets$2.6B-3.5%

Cash flow

Operating cash flow$86.7M+111%

CapEx$9.1M-10.2%

Free cash flow$77.6M+150%

Valuation

Market cap$9.07B-11.8%

Enterprise value$9.15B-13.6%

P/E60.6×+13.6×

P/S7.5×-1.0×

Profitability

Gross margin65%-0.8pp

Operating margin14.2%-7.9pp

Net margin10.9%-6.7pp

FCF margin22.3%+4.0pp

Returns & leverage

Return on equity6.5%-3.9pp

Debt / equity0.1×-0.1×

Current ratio4.5×+0.8×

Where this comes from

Reported directly by Bio-Techne in its filing.

Tagged under the XBRL concept us-gaap:ReceivablesFairValueDisclosure.

The official record: Bio-Techne’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bio-Techne's exosome diagnostics inc — receivables fair value disclosure.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Bio-Techne's exosome diagnostics inc — receivables fair value disclosure?: Bio-Techne (TECH) reported exosome diagnostics inc — receivables fair value disclosure of $9M in Q1 2026.
What does exosome diagnostics inc — receivables fair value disclosure mean?: The fair value of receivables associated with the Exosome Diagnostics business unit, as disclosed in financial notes. This metric provides an assessment of the current market value of outstanding debts owed to the segment. It is used to evaluate the credit quality and potential collectability of these assets.